Having trouble accessing articles? Reset your cache.

Novartis exercises Alcon option

Novartis AG (NYSE:NVS; SIX:NOVN) exercised its option to acquire 52% of Alcon Inc. (NYSE:ACL) from Nestle

Read the full 160 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE